prostate radiotherapy

Prostate Cancer

Radioactive Seed Implant: Ultrasound-guided Permanent Seed Prostate Brachytherapy

By Donald B. Fuller, M.D.

Print This PageMake Text BiggerMake Text Smaller

Radioactive Seed Implant

References

  1. Blasko, JC, et al; Palladium-103 brachytherapy for prostate carcinoma; Int J Radiat Oncol Biol Phys; 2000 Mar 1; 46(4):839-850
  2. Grimm, PD, et al; 10-year biochemical (prostate-specific-antigen) control of prostate cancer with I-125 brachytherapy; Int J Radiat Oncol Biol Phys; 2001 Sept 1;51(1):273-278
  3. Potters L, et al; The role of external beam irradiation in patients undergoing prostate brachytherapy; Urol Oncology, 2000 Apr 1; 5(3):112-117
  4. Ragde, H, et al; Modern prostate brachytherapy. Prostate-specific antigen results in 219 patients with up to 12 years of observed follow-up; Cancer; 2000 Jul 1;89(1):135-141
  5. Blasko, JC, et al; The role of external beam radiotherapy with I-125/Pd-103 brachytherapy for prostate carcinoma; Radiother Oncol, 2000 Dec; 57(3):273-278
  6. Potters, L, et al; A comprehensive review of CT-based dosimetry parameters and biochemical control in patients treated with permanent prostate brachytherapy; Int J Radiat Oncol Biol Phys; 2002 Jul 1;50(3):605-614
  7. Lee, WR, et al; A prospective quality of life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy or interstitial brachytherapy; Int J Radiat Oncol Biol Phys; 2001 Nov 1; 51(3): 614-623
  8. Fuller, D.B., et al, Office-based CT-ultrasound interactive transperineal prostate brachytherapy: a real-time dosimetry analysis and quality improvement method – report of 14 cases. Brachytherapy, vol. 2(1), May 2003, p-63
  9. Fuller, D.B., et al, Prostate brachytherapy using conscious sedation and local anesthesia: patient satisfaction survey, morbidity assessment and implant quality assessment. Brachytherapy, vol. 2(1), May 2003, p 63-64